OGEN vs WELL · rev $37.7K vs P/E 100, rev $10.84B
Oragenics Inc (OGEN) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
OGEN currently screens at market cap $2.7M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the OGEN and WELL stock pages for the full models.
Not investment advice.